FDA Clears PRD-101 Nano Cancer Drug for Phase 1
SEONGNAM, South Korea, Feb. 6, 2026 — PharmaResearch Co., Ltd. announced that the U.S. Food and Drug Administration (FDA)...
Phase 1 Clinical Trial
Advertisement
Phase 1 Gene Therapy Data Shows Promise in Stargardt Disease
MALVERN, Pa., January 12, 2026 — Ocugen, Inc. announced the peer-reviewed publication of positive Phase 1 GARDian1 clinical trial...
QurAlis Shows ALS Target Engagement in Phase 1 Trial
CAMBRIDGE, Massachusetts — QurAlis Corporation has announced topline Phase 1 proof-of-mechanism clinical data demonstrating clear target engagement in patients...
Sagimet Advances MASH Combination Therapy With Phase 1 PK Data
SAN MATEO, Calif., Dec. 18, 2025 — Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company focused on metabolic and fibrotic...
Vivace Therapeutics Gains FDA Fast Track Designation for VT3989 in Mesothelioma
SAN MATEO, Calif., October 8, 2025 — Vivace Therapeutics, Inc., a biotechnology company pioneering small molecule cancer therapies that...
Advertisements
Anixa Biosciences Completes Final Patient Visit in Breast Cancer Vaccine Trial
SAN JOSE, Calif., October 7, 2025 – Anixa Biosciences, Inc. (NASDAQ: ANIX), a clinical-stage biotechnology company dedicated to cancer...
Advertisement
